DESOUZA ERROL B

CIK 00012138957 companiesPARAMUS, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001213895

Recent Transactions

50 trades

Award
Alector, Inc.$ALEC
Common Stock
2025-06-11+28,700→ 69,950 total
Award
Alector, Inc.$ALEC
Stock Option (right to buy)
2025-06-11+9,450→ 9,450 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-13+7,614→ 81,352 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-06-07+9,293→ 73,738 total
Award
Alector, Inc.$ALEC
Stock Option (right to buy)
2024-03-19+19,420→ 19,420 total
Award
Alector, Inc.$ALEC
Common Stock
2024-03-19+41,250→ 41,250 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Common Stock
2023-11-30+20,000→ 50,000 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Common Stock
2023-11-30+30,000→ 30,000 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-06-23+7,747→ 64,445 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-06-24+6,328→ 56,698 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Stock Option (Right to Buy)
2022-06-14+20,000→ 20,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2021-10-01+3,588→ 29,801 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2021-07-01+3,406→ 26,213 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-06-25+5,726→ 50,370 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Stock Option (Right to Buy)
2021-06-24+10,000→ 10,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2021-06-09+14,000→ 14,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2021-04-01+2,926→ 22,807 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2021-01-05+2,129→ 19,881 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2020-10-01+3,125→ 17,752 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2020-07-01+2,129→ 14,627 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-06-18+8,929→ 44,644 total
Award
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2020-06-15+53,915→ 53,915 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-06-15+35,715→ 35,715 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2020-06-11+5,000→ 5,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2020-04-01+2,860→ 12,498 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2020-01-02+1,835→ 9,638 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2019-10-01+2,545→ 7,803 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2019-07-01+1,810→ 5,258 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2019-06-13+5,000→ 5,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2019-04-01+1,504→ 3,448 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2018-12-31+1,703→ 1,944 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-06-13+5,000→ 5,000 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Redeemable Convertible Note
2018-02-20−4,679→ 0 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Redeemable Convertible Note
2018-02-20
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2017-07-13+10,000→ 10,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2016-06-09+7,500→ 7,500 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+8,250→ 8,250 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+6,750→ 6,750 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+6,750→ 6,750 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Common Stock
2015-09-30+131,128→ 202,885 total
Tax Payment
ALBIREO PHARMA, INC.
Common Stock
2015-09-30$0.44/sh−43,469→ 159,416 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Restricted Stock Unit
2015-09-30→ 0 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Redeemable Convertible Note
2015-08-14
Award
ALBIREO PHARMA, INC.
Stock Option (Right to Buy)
2014-12-19+225,000→ 225,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2014-12-11+10,000→ 15,333 total
Award
ALBIREO PHARMA, INC.
Restricted Stock Units
2014-11-11+131,128→ 131,128 total
Tax Payment
ALBIREO PHARMA, INC.
Common Stock
2014-03-12−1,760→ 71,757 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Common Stock
2014-03-12+5,625→ 73,517 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Restricted Stock Unit
2014-03-12+5,625→ 0 total
Award
ALBIREO PHARMA, INC.
Stock Option (Right to Buy)
2013-12-23+300,000→ 300,000 total

DESOUZA ERROL B

Recent Transactions

Companies

Recent Filings

Address